SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec increases availability of life saving drug ‘Cilamin250 Capsules’ in India

03 Jan 2017 Evaluate

Panacea Biotec, India’s leading Biotechnology Company has increased availability of Life Saving Drug Cilamin250 (D-Penicillamine IP 250mg) Capsules used for treatment of Wilson’s disease in India. The production of its brand Cilamin 250 Capsules has increased due to the receipt of additional quantity of raw material. Cilamin 250 Capsule is used for treatment of Wilsons disease, Rheumatoid Arthritis and other conditions witnessed short supply in the market during the last few months due to non-availability of raw material D-Penicillamine in India.

Panacea Biotec had already released limited quantities on 9th of December 2016 to select stockiest all over India. Additional quantity has now been made available starting from 2nd January 2017 at different stockiest all over India. The company is in regular touch with Department of Pharmaceuticals, NPPA and Drug Controller General of India for facilitating regular supplies of Cilamin250 capsules in the market.

Panacea Biotec is the largest biotechnology company as well as among the top 50 pharmaceutical companies of India. The company has product portfolio that’s caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal.


Panacea Biotec Share Price

358.00 5.30 (1.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×